| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |